Coronary Physiology: Techniques, Cases and Co-registration

Dr. Dib is board certified in cardiovascular disease and interventional cardiology. In addition, he has completed extensive training in nuclear cardiology and is certified by the Certification Board of Nuclear Cardiology. His clinical interests include coronary artery disease and interventions, peripheral artery disease and interventions, structural heart disease, venous disease, ablation, thrombectomy, pacemaker implantation and interrogation. After finishing his internship and residency training at Mayo Clinic, Dr. Dib went on to complete a fellowship in Cardiovascular Disease at the University of Oklahoma Health Sciences Center in Oklahoma City and a fellowship in Interventional Cardiology at the University of Texas Health Science Center in Houston. He is also a fellow of the American College of Cardiology and the Society of Cardiac Angiography and Interventions. Dr. Dib is on the medical staff at The Heart Hospital Baylor Plano and Baylor Scott & White Medical Center – McKinney. He is currently welcoming new patients.

Dr Justin Davies is a board member of Monaco Cardio at the Princess Grace Hospital, Monaco, and an interventional cardiologist with over 15 years of experience as a leading educator in the field. His clinical and academic career was established at Hammersmith Hospital, Imperial College London, where he built an international reputation for innovation in cardiovascular medicine. Over the course of his career, he has successfully mentored 15 PhD students, published more than 500 peer-reviewed papers — including landmark studies in the New England Journal of Medicine and The Lancet — and holds 20 patents in cardiovascular medicine and technology. He was the co-principal investigator of the DEFINE-FLAIR study, which helped establish iFR (Instantaneous Wave-Free Ratio), a diagnostic technique he invented, as a globally adopted standard in coronary physiology. His work reflects a unique blend of scientific innovation, academic leadership, and clinical excellence. In addition to his research and academic commitments, Justin is CEO of Cerebria AI, where he leads the development of next-generation AI-powered cardiovascular imaging and physiology tools. Under his leadership, Cerebria AI is advancing cutting-edge solutions that integrate artificial intelligence with frontline cardiology to enhance clinical decision-making and patient outcomes. Combining deep clinical expertise with entrepreneurial vision, he continues to guide international ventures through funding, regulatory pathways, and commercialization, while remaining committed to transforming cardiovascular care on a global scale.

Dr. Karim Al-Azizi is an Interventional Cardiologist and Structural Heart Disease specialist at Baylor Scott & White Health - The Heart Hospital in Plano, TX. He is the Medical Director of the Cardiac Catheterization Laboratories and the Associate Program Director of the Cardiovascular disease fellowship and a clinical assistant professor at the Texas A and M College of Medicine. His clinical and research interests include complex coronary interventions, ultra-low contrast, physiology and imaging-guided PCI, and transcatheter interventions for valvular heart disease. He speaks at national and international conferences on these subjects and serves as a principal investigator on multiple clinical trials in the field of structural and coronary interventions.

Srini Potluri, MD, FACC FSCAI is chairman of cardiology at Baylor Scott and White The Heart Hospital Plano, medical director of their cardiac catheterization laboratory and associate professor at Texas A&M. He also serves as the program director of interventional cardiology fellowship. He is on the board of Baylor Scott and White Cardiovascular Governance Council assisting in improving system wide cardiovascular quality and operations. He joined Baylor Scott and White Legacy Heart Center from the Ochsner Clinic Foundation in New Orleans, Louisiana where he completed fellowships in cardiology and interventional cardiology. During his training he served as chief resident and chief interventional fellow and also received several awards in research and clinical excellence. His clinical interests are complex coronary interventions, chronic total occlusion intervention, transcatheter heart valve replacement, septal defect closures, left atrial appendage closures. In his busy practice he serves patients from North Texas and surrounding areas. He was named the best doctor in Dallas for several years. He is well published in the field of coronary and structural intervention and principal investigator in several national and global clinical research trials. He also serves on several industry advisory boards and actively participates and speaks at major national cardiovascular meetings. He lives in Frisco, TX with his wife and three daughters.